B

Britannia Life Sciences Inc
F:L020

Watchlist Manager
Britannia Life Sciences Inc
F:L020
Watchlist
Price: 0.041 EUR -1.2%
Market Cap: 16.7m EUR

Britannia Life Sciences Inc
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Britannia Life Sciences Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
B
Britannia Life Sciences Inc
CNSX:BLAB
Net Income (Common)
CA$7.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Canopy Growth Corp
TSX:WEED
Net Income (Common)
-CA$385.9m
CAGR 3-Years
50%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Aurora Cannabis Inc
TSX:ACB
Net Income (Common)
-CA$58.9m
CAGR 3-Years
68%
CAGR 5-Years
56%
CAGR 10-Years
-19%
OrganiGram Holdings Inc
TSX:OGI
Net Income (Common)
-CA$24.8m
CAGR 3-Years
-20%
CAGR 5-Years
29%
CAGR 10-Years
-34%
Sundial Growers Inc
NASDAQ:SNDL
Net Income (Common)
-CA$92.3m
CAGR 3-Years
30%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Net Income (Common)
$36.1m
CAGR 3-Years
N/A
CAGR 5-Years
-18%
CAGR 10-Years
N/A
No Stocks Found

Britannia Life Sciences Inc
Glance View

Market Cap
16.7m EUR
Industry
N/A

Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.

L020 Intrinsic Value
0.027 EUR
Overvaluation 34%
Intrinsic Value
Price
B

See Also

What is Britannia Life Sciences Inc's Net Income (Common)?
Net Income (Common)
7.4m CAD

Based on the financial report for Mar 31, 2025, Britannia Life Sciences Inc's Net Income (Common) amounts to 7.4m CAD.

Back to Top